Clinical TrialsSearch results
Number of results: 525
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Efficacy of rosuvastatin for the treatment of nonalcoholic steatohepatitis with hyperlipidemia
- nonalcoholic fatty liver disease
- Hiroshima University Hospital
- 2007-06-01
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Other
- Phase II study of cisplatin, docetaxel, and irinotecan, followed by gefitinib, gemcitabine and vinorelbine for patients with non-small-cell lung cancer harboring active EGFR gene mutations (OLCSG0704)
- non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2009-08-01
Other
- A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy (SKYSCRAPER-15)
- Non-small Cell Lung Cancer (NSCLC)
- Raymond Meng
- 2024-03-14
Other
- Phase II study of gefitinib in patients with EGFR mutation positive- advanced non-small cell lung cancer
- non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-09
Other
- Does gefitinib prolong the survival of adenocarcinoma patients against non-adeno non-small cell lung cancer? A retrospective study.
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-07-23
Other
- A Phase I Study of Concurrent Chemotherapy using TS-1 with Involved Field Radiotherapy for Elderly Patients with Non-Small Cell Lung Cancer.
- Non-Small Cell Lung Cancer
- Hiroshima Radiation Oncology Study Group
- 2009-07-03
Not yet recruiting
- Phase 3 study of Adjuvant V940 and Pembrolizumab in Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer
- Fujita Tomoko
- 2024-10-08
Recruiting
- Phase II study of combination treatment of nivolumab and TM5614 for non-small cell lung cancer (TM-Uprise Study)
- non-small cell lung cancer
- Hattori Noboru
- 2023-07-19
Recruiting
- A phase II randomized trial of adjuvant chemotherapy for the patients completely resected pathological stage IB(T>5cm), II, IIIA Non Small Cell Lung Cancer comparing S-1 / S-1 with CDDP
- non-small cell lung cancer
- Kyushu University,Graduate School of Medical Science,Department of Surgery and Science
- 2009-03-12